Evaxion Biotech AS (EVAX)
1.49
+0.12
(+8.76%)
USD |
NASDAQ |
Nov 22, 16:00
1.42
-0.07
(-4.70%)
After-Hours: 20:00
Evaxion Biotech Total Return Price: 1.49 for Nov. 22, 2024
Total Return Price Chart
Historical Total Return Price Data
Date | Value |
---|---|
November 22, 2024 | 1.49 |
November 21, 2024 | 1.37 |
November 20, 2024 | 1.40 |
November 19, 2024 | 1.560 |
November 18, 2024 | 1.63 |
November 15, 2024 | 1.44 |
November 14, 2024 | 1.68 |
November 13, 2024 | 1.76 |
November 12, 2024 | 2.38 |
November 11, 2024 | 2.42 |
November 08, 2024 | 2.50 |
November 07, 2024 | 2.62 |
November 06, 2024 | 2.57 |
November 05, 2024 | 2.61 |
November 04, 2024 | 2.64 |
November 01, 2024 | 2.59 |
October 31, 2024 | 2.67 |
October 30, 2024 | 2.76 |
October 29, 2024 | 2.91 |
October 28, 2024 | 2.84 |
October 25, 2024 | 2.76 |
October 24, 2024 | 2.65 |
October 23, 2024 | 2.67 |
October 22, 2024 | 2.56 |
October 21, 2024 | 2.54 |
Date | Value |
---|---|
October 18, 2024 | 2.64 |
October 17, 2024 | 2.71 |
October 16, 2024 | 2.71 |
October 15, 2024 | 2.60 |
October 14, 2024 | 2.69 |
October 11, 2024 | 2.60 |
October 10, 2024 | 2.63 |
October 09, 2024 | 2.68 |
October 08, 2024 | 2.84 |
October 07, 2024 | 2.85 |
October 04, 2024 | 2.95 |
October 03, 2024 | 3.06 |
October 02, 2024 | 2.98 |
October 01, 2024 | 2.93 |
September 30, 2024 | 3.11 |
September 27, 2024 | 3.12 |
September 26, 2024 | 3.06 |
September 25, 2024 | 2.83 |
September 24, 2024 | 2.97 |
September 23, 2024 | 2.95 |
September 20, 2024 | 2.99 |
September 19, 2024 | 3.15 |
September 18, 2024 | 3.12 |
September 17, 2024 | 3.03 |
September 16, 2024 | 3.25 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
1.37
Minimum
Nov 21 2024
126.80
Maximum
Nov 04 2021
26.89
Average
17.40
Median
May 13 2022
Total Return Price Benchmarks
Ascendis Pharma AS | 129.81 |
DBV Technologies SA | 0.469 |
Adaptimmune Therapeutics PLC | 0.6616 |
Akari Therapeutics PLC | 1.30 |
Biodexa Pharmaceuticals PLC | 4.57 |